期刊文献+

血浆B型脑钠肽对急性冠脉综合征的病情影响及预后评估 被引量:9

Plasma B-Type Natriuretic Peptide Role for Evaluation of Pathogenetic Condition and Outcome of Acute Coronary Syndrome
原文传递
导出
摘要 目的:探讨血浆B型脑钠肽(BNP)对急性冠脉综合征的病情影响及预后评估的作用,为临床实践提供参考。方法:分别对30例健康体检者(对照组)和81例ACS患者(观察组)检测其入院24小时内的血浆BNP浓度,并在住院一周内行冠状动脉造影术,检查病变的冠脉支数。结果:观察组的血浆BNP浓度高于对照(P<0.01),病变动脉支数与BNP水平呈正相关(P<0.01)。结论:BNP是急性冠脉综合征发病的重要因素,其水平高低可反映病情的严重程度,是预测病情和预后的重要指标。临床上应有效的监测BNP水平,对正确诊断和有效治疗急性冠脉综合征具有重要的意义。 Objective: To study the role of plasma B-type natriuretic peptide to evaluate the pathogenetic condition and outcome of acute coronary syndrome. Methods: 81 patients with ACS (observation group) and 30 health examination persons (controlling group) were enrolled in this study. Plasma levels of BNP were detected in 24 hours after hospitalization and coronary angiography were performed for detecting the affected coronary arteries in a week. Results: Plasma levels of BNP of the observation group were higher than those of the controlling group (P〈0.01). The correlation was positive between the number of affected coronary arteries and the levels of BNP(P〈 0.01 ). Conclusion: BNP was an important factor in the pathogenesy of ACS; the levels of BNP may reflect the severity of ACS, and BNP can be an important index to evaluate the pathogenetic condition and outcome. Monitoring the BNP level effectively in clinic possesses is considered significant significance to diagnose exactly and reasonable treatment for acute coronary syndrome.
出处 《现代生物医学进展》 CAS 2012年第22期4324-4326,4341,共4页 Progress in Modern Biomedicine
关键词 急性冠脉综合征 B型脑钠肽 病情 预后 Acute Coronary Syndrome B-Type Natriuretic Peptide Pathogenetic Condition Outcome
  • 相关文献

参考文献20

  • 1de Lemos JA, Marrow DA, Bentley JH, et al. Theprognostic valueof B- type natriuretic peptidein patients with acute coronary syndromes [J]. Engl J Med, 2001, 345:1014-1021.
  • 2冯文化.血浆脑钠素水平对急性冠脉综合征预后的意义[J].心血管康复医学杂志,2008,17(2):131-133. 被引量:3
  • 3Sagnella GA. Measurement and significance of circulating natriuretic peptide in cardiovascular disease [ J]. Clin Sei (lond), 1998, 95:519-529.
  • 4lwanaga Y, Ni shi I, Furui chi S, et al. B-type natriuretic peptide stro- ngly reflects diastolic wall stress in patients with chroni cheart failure: Comparison between systolic and diastolic heart failure [J]. J Am Coll Cardiol, 2006, 47:742-748.
  • 5Asada J, Tsuji H, lwasaka T,et al. Useful ness of plasma brain natriure- tic peptide levels in predicting dobutamine induced myocardiali sche- mia[J]. Am J Cardiol, 2004, 93:702-704.
  • 6Hopkins WE, Chen Z, Fukagawa NK, et al. Increased at rial and brain natriuretic peptide in adults with cyanotic congenital heart disease [J]. Circulation, 2004, 109:2872-2877.
  • 7丁嵩,何奔,孙瑜,刘建平,杜勇平,沈节艳,金叔宣,沈珑.稳定型心绞痛及急性冠脉综合征患者脑钠肽浓度的变化和意义[J].中国心血管病研究,2005,3(12):890-892. 被引量:20
  • 8I Morita E, Yasue H, Yoshimura M, et al. Increased plasma levels ofbrain natriuretic peptide in patients with acute myocardi alinfarction [J]. Circulation, 1993, 88:82-91.
  • 9Aylin Y, Sadik A, Cagatay E, et al. Effects of lesion complexity on ba- seline and post procedural B-type natriuretic peptide levels in patients undergoing percutaneous coronary interventions [J]. Tex Heart Inst J, 2007, 34:282-289.
  • 10胡昊,李凤,丁晓梅.血浆脑钠肽在急性冠脉综合征患者的变化及与冠脉病变范围的关系[J].中国心血管病研究,2008,6(8):591-593. 被引量:22

二级参考文献97

共引文献144

同被引文献76

  • 1胡蓉,方先松,江丽霞,曹娟.冠心病患者血清Lp-PLA2及hs-CRP水平与冠状动脉粥样硬化易损斑块的相关性[J].中国老年学杂志,2015,35(1):74-75. 被引量:37
  • 2Miller WL, Hartman KA, Grill DE,et al. Only large reductions in con-centrations of natriuretic peptides(BNP and NT-proBNP) are associat-ed with improved outcome in ambulatory patients with chronic heartfailure[ J]. Clin Chem,2009,55(1〉:78-84.
  • 3Aguilera-Herrador E, Cruz-Vera M, Valcdrcel M. Analytical connota-tions of point-of-care testing[ J] . Analyst,2010,135 (9 ) :2220-2232.
  • 4Lichtarska D,Feldman R. Troponin positive acute coronary syndromesin the course of acute carbon monoxide poisoning as the factor exposingprimary coronary heart disease previously undiagnosed [ J ]. PrzeglLek,2011,68(8) :510-514.
  • 5Carlsen, C. M., Bay, M., Kirk, V., et al. Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: A 10-year analysis from the Copenhagen Hospital Heart Failure Study [J]. European journal of heart failure, 2012, 14(3): 240-247.
  • 6Thejus J, Francis J. N-terminal Pro-Brain Natriuretic Peptide and Atrial Fibrillation[J]. Indian Pacing Electrophysiol J, 2009, 9(1): 1-4.
  • 7Chen, C. -Y , Yoshida, A. , Asakura, M. et al. Serum Blood Urea Nitrogen and Plasma Brain Natriuretic Pepfide and Low Diastolic Blood Pressure Predict Cardiovascular Morbidity and Mortality Following Discharge in Acute Decompensated Heart Failure Patients [J]. Circulation journal, 2012, 76(10): 2372-2379.
  • 8Romano S, Necozione S, Guarracini L, et al. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of lett ventricular dysfunction in high-risk asymptomatic patients[J]. J Cardiovasc Med, 2009, 10(3): 238-244.
  • 9Khan SQ, Narayan H, Ng KH, et al. N-terminal pro B type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome[J]. Clin Sci (Lond), 2009, 117(1): 31-39.
  • 10Mazovets OL, Trifonov 1R, Katrukha AG, et al. Admission and Prediseharge Levels of NT pre Brain Natriuretic Peptide in Patients Hospitalized Because of Worsening Heart Failure. Relation to Risk of Death in the Next 6-12 Months[J]. Kardiologiia, 2009, 49(1): 34-38.

引证文献9

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部